Comparison of Two Hepatitis B Vaccination Strategies Targeting Vertical Transmission: A 10-Year Japanese Multicenter Prospective Cohort Study
Open Access
- 17 January 2021
- Vol. 9 (1), 58
- https://doi.org/10.3390/vaccines9010058
Abstract
In 1985, a hepatitis B (HB) vaccination strategy against vertical HB virus transmission was introduced in Japan that recommended vaccination of infants at two, three, and five months of age (delayed strategy). This schedule was revised in 2013, recommending to vaccinate at birth and at 1 and 6 months of age (non-delayed strategy). We aimed to compare the vertical HB virus transmission rates and immunogenic responses between these two vaccination strategies. This Japanese multicenter prospective cohort study included 222 infants born between 2008 and 2017 to serum hepatitis B surface (HBs) antigen (HBsAg)-positive mothers. During the study period, 136 and 86 infants received delayed and non-delayed strategies, respectively. A positive vertical HB virus transmission was defined as a positive serum HBsAg status. Seropositive immunogenic response was defined as a serum anti-HBs titer of ≥10 mIU/mL. Post-vaccination serum HBsAg positivity rates did not differ significantly between the delayed (0/136 [0.0%, 95% confidence interval, 0.0–2.7%]) and non-delayed (2/86 [2.3%, 95% confidence interval, 0.3–8.1%]) strategy groups. Seropositive immunogenic response rates were 100.0% (136/136) and 97.7% (84/86), respectively. Although this study was under-powered to detect a statistically significant result, no vertical HB virus transmission was observed in the delayed strategy.This publication has 21 references indexed in Scilit:
- Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis BGut, 2011
- Comparison of the Japanese and the international hepatitis B vaccine scheduleKanzo, 2010
- Hepatitis B virus S gene escape mutantsAsian Journal of Transfusion Science, 2007
- Hepatitis B virus genotypesVaccine, 2005
- Immunization of Preterm and Low Birth Weight InfantsPEDIATRICS, 2003
- What Level of Hepatitis B Antibody Is Protective?The Journal of Infectious Diseases, 1999
- Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccinationVaccine, 1996
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990
- National Project on the Prevention of Mother-to-Infant Infection by Hepatitis B Virus in JapanPediatrics International, 1989
- PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINEThe Lancet, 1983